ArticleWorld journal of gastroenterology2022

Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn's disease under infliximab therapy.

Wan-Ting Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.